These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6392979)

  • 1. Gel tears. A new medication for the treatment of dry eyes.
    Leibowitz HM; Chang RK; Mandell AI
    Ophthalmology; 1984 Oct; 91(10):1199-204. PubMed ID: 6392979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of 0.3% carbomer gel compared to placebo in patients with moderate-to-severe dry eye syndrome.
    Sullivan LJ; McCurrach F; Lee S; Taylor HR; Rolando M; Marechal-Courtois C; Creuzot-Garcher C; Easty DL; Karabatsas C; Bingh Hoh M; Faschinger C; Laroche L
    Ophthalmology; 1997 Sep; 104(9):1402-8. PubMed ID: 9307633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three percent diquafosol ophthalmic solution as an additional therapy to existing artificial tears with steroids for dry-eye patients with Sjögren's syndrome.
    Yokoi N; Sonomura Y; Kato H; Komuro A; Kinoshita S
    Eye (Lond); 2015 Sep; 29(9):1204-12. PubMed ID: 26160526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the efficacy and safety of two eye gels in the treatment of dry eyes: Lacrinorm and Viscotears.
    Bron AJ; Daubas P; Siou-Mermet R; Trinquand C
    Eye (Lond); 1998; 12 ( Pt 5)():839-47. PubMed ID: 10070521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative assessment of the efficacy of carbomer gel and carboxymethyl cellulose containing artificial tears in dry eyes.
    Xiao Q; Hu Y; Chen F; Chen X
    J Huazhong Univ Sci Technolog Med Sci; 2008 Oct; 28(5):592-5. PubMed ID: 18846346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyacrylic acid gel in patients with dry eyes: a randomised comparison with polyvinyl alcohol.
    Bron AJ; Mangat H; Quinlan M; Foley-Nolan A; Eustace P; Fsadni M; Sunder Raj P
    Eur J Ophthalmol; 1998; 8(2):81-9. PubMed ID: 9673476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of polyacrylic acid (Viscotears) liquid gel versus polyvinylalcohol in the treatment of dry eyes.
    Brodwall J; Alme G; Gedde-Dahl S; Smith J; Lilliedahl NP; Kunz PA; Sunderraj P
    Acta Ophthalmol Scand; 1997 Aug; 75(4):457-61. PubMed ID: 9374260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of topical cyclosporine a plus artificial tears versus artificial tears treatment on conjunctival goblet cell density in dysfunctional tear syndrome.
    Demiryay E; Yaylali V; Cetin EN; Yildirim C
    Eye Contact Lens; 2011 Sep; 37(5):312-5. PubMed ID: 21792057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of cyclosporine 0.05% ophthalmic emulsion versus vehicle in Chinese patients with moderate to severe dry eye disease: an eight-week, multicenter, randomized, double-blind, parallel-group trial.
    Chen M; Gong L; Sun X; Xie H; Zhang Y; Zou L; Qu J; Li Y; He J
    J Ocul Pharmacol Ther; 2010 Aug; 26(4):361-6. PubMed ID: 20698799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corneal surface regularity and the effect of artificial tears in aqueous tear deficiency.
    Liu Z; Pflugfelder SC
    Ophthalmology; 1999 May; 106(5):939-43. PubMed ID: 10328393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of local acetylcysteine and artificial tears in the management of dry eye syndrome].
    Pokupec R; Petricek I; Sikić J; Bradić M; Popović-Suić S; Petricek G
    Acta Med Croatica; 2005; 59(4):337-40. PubMed ID: 16334742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group.
    Stevenson D; Tauber J; Reis BL
    Ophthalmology; 2000 May; 107(5):967-74. PubMed ID: 10811092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of artificial tears on corneal surface regularity, contrast sensitivity, and glare disability in dry eyes.
    Huang FC; Tseng SH; Shih MH; Chen FK
    Ophthalmology; 2002 Oct; 109(10):1934-40. PubMed ID: 12359618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-masked trial of topical ketorolac versus artificial tears for treatment of viral conjunctivitis.
    Shiuey Y; Ambati BK; Adamis AP
    Ophthalmology; 2000 Aug; 107(8):1512-7. PubMed ID: 10919900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of topical Healon tears in the management of refractory dry-eye syndrome.
    DeLuise VP; Peterson WS
    Ann Ophthalmol; 1984 Sep; 16(9):823-4. PubMed ID: 6508097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years.
    Barber LD; Pflugfelder SC; Tauber J; Foulks GN
    Ophthalmology; 2005 Oct; 112(10):1790-4. PubMed ID: 16102833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group.
    Sall K; Stevenson OD; Mundorf TK; Reis BL
    Ophthalmology; 2000 Apr; 107(4):631-9. PubMed ID: 10768324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin A Palmitate and Carbomer Gel Protects the Conjunctiva of Patients With Long-term Prostaglandin Analogs Application.
    Cui X; Xiang J; Zhu W; Wei A; Le Q; Xu J; Zhou X
    J Glaucoma; 2016 Jun; 25(6):487-92. PubMed ID: 26317483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The increase of aqueous tear volume by diquafosol sodium in dry-eye patients with Sjögren's syndrome: a pilot study.
    Yokoi N; Kato H; Kinoshita S
    Eye (Lond); 2016 Jun; 30(6):857-64. PubMed ID: 27055679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facilitation of tear fluid secretion by 3% diquafosol ophthalmic solution in normal human eyes.
    Yokoi N; Kato H; Kinoshita S
    Am J Ophthalmol; 2014 Jan; 157(1):85-92.e1. PubMed ID: 24200231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.